Two papers from University College London show that having early chemotherapy improves survival for men with prostate cancer. Read the article.
Early chemotherapy improves survival for men with prostate cancer Read More »
A survey showed men who underwent radical prostatectomy, especially robotic radical prostatectomy, had unrealistic expectations about how well they would function sexually postoperatively. Read the article.
Men Unclear on Sexual Function After Prostatectomy Read More »
A new genomic test, Oncotype DX, gauges how lethal a tumor is by looking at the expression of 17 genes in the tumor. Read the article.
New Diagnostic Tools for Prostate Cancer Read More »
Click here to view, in cartoon form, some of our basic tips for all of your visits. (You have to click on the row of cartoons to view them.)
7 Tips for a Successful First Visit to Your Oncologist Read More »
A recent study out of Johns Hopkins shows that a new and simple grading system may be effective for predicting outcomes in men with prostate cancer. In fact, the researchers say the test — in an analysis of 20,000 men — appears to be an improvement over the Gleason grading system, the current standard. Read the article.
New Prostate Cancer Grading System Found Superior to Gleason System Read More »
Health of more than 26,000 men, aged over 30, was tracked for five years. Avoiding all animal-related foods cut odds of the cancer by 35 per cent. Those who ate eggs and dairy just as likely to get disease as meat eaters Read the article.
Going VEGAN slashes the risk of prostate cancer by a third Read More »
The results of a study support an association between the use of androgen deprivation therapy (ADT) in the treatment of prostate cancer and an increased risk of Alzheimer’s disease in a general population cohort. Read the article.
Common prostate cancer treatment may double Alzheimer’s risk Read More »
A 2013 study published in the International Journal of Cancer raises concerns about alcohol’s ability to throw off prostate cancer tests. The investigators found a modestly higher risk of prostate cancer among heavy drinkers; they also observed evidence of lower PSA levels associated with increasing consumption of alcohol. This means it can be more difficult to detect prostate cancer using PSA levels among men who are heavy drinkers. In an older study of Harvard alumni, researchers concluded wine or beer consumption was unassociated with prostate cancer; however, moderate liquor consumption was associated with a significant 61-67 percent increased risk of
Alcohol, especially liquor, increases prostate risk and skews PSA Read More »
The optimal treatment of clinically localized prostate cancer is controversial. Most studies focus on biochemical (PSA) failure when comparing radical prostatectomy (RP) with radiation therapy (RT), but this endpoint has not been validated as predictive of overall survival (OS) or cause-specific survival (CSS) The available literature was analyzed to determine whether reliable conclusions could be made concerning the effectiveness of RP compared with RT with or without androgen deprivation therapy (ADT). Reliable evidence that RP provides a superior CSS to RT with ADT is lacking. The most reliable studies suggest that the differences in 10-year CSS between RP and RT
The treatment uses a virus hidden in immune cells that seek and destroy cancer cells from within. Trials on rodents have cured cancerous growths and were alive and cancer free at the end of the 40 day study. Fifteeen British men are to start a clinical trial using the technique – the first time it has been tested in humans. Read the article.
New Cancer treatment promises to ‘obliterate’ tumours Read More »